A detailed history of Gsa Capital Partners LLP transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 14,230 shares of SLP stock, worth $516,264. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,230
Holding current value
$516,264
% of portfolio
0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$27.22 - $34.28 $387,340 - $487,804
14,230 New
14,230 $397,000
Q3 2023

Nov 15, 2023

BUY
$40.03 - $51.51 $593,204 - $763,326
14,819 New
14,819 $617,000
Q4 2022

Feb 13, 2023

BUY
$36.55 - $51.15 $41,045 - $57,441
1,123 Added 8.45%
14,414 $527,000
Q3 2022

Nov 14, 2022

BUY
$47.75 - $66.88 $634,645 - $888,902
13,291 New
13,291 $645,000
Q4 2021

Feb 14, 2022

SELL
$37.1 - $57.45 $241,446 - $373,884
-6,508 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$38.45 - $55.66 $176,216 - $255,089
-4,583 Reduced 41.32%
6,508 $257,000
Q2 2021

Aug 05, 2021

BUY
$49.67 - $68.96 $550,889 - $764,835
11,091 New
11,091 $609,000
Q3 2019

Nov 12, 2019

SELL
$28.19 - $41.75 $557,710 - $825,982
-19,784 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$19.91 - $28.97 $20,726 - $30,157
-1,041 Reduced 5.0%
19,784 $565,000
Q1 2019

May 15, 2019

SELL
$18.84 - $21.36 $30,144 - $34,176
-1,600 Reduced 7.13%
20,825 $440,000
Q3 2018

Nov 13, 2018

BUY
$17.1 - $23.55 $102,600 - $141,300
6,000 Added 36.53%
22,425 $453,000
Q2 2018

Aug 09, 2018

SELL
$14.65 - $23.75 $38,295 - $62,082
-2,614 Reduced 13.73%
16,425 $365,000
Q1 2018

May 11, 2018

SELL
$14.4 - $16.8 $7,200 - $8,400
-500 Reduced 2.56%
19,039 $281,000
Q4 2017

Feb 14, 2018

SELL
$15.3 - $17.4 $421,836 - $479,735
-27,571 Reduced 58.52%
19,539 $315,000
Q3 2017

Nov 20, 2017

BUY
$13.7 - $15.65 $645,407 - $737,271
47,110
47,110 $730,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $736M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.